Transcript
TREATMENT FAILURE OF MALARIA CONTROL IN PAKISTAN
INTRODUCTION DEFINITION
“An infective disease caused by sporozoan parasites that are transmitted through the bite of an infected Anopheles mosquito; marked by paroxysms of chills and fever.”
Malaria is the most important of the parasitic diseases of humans present in 107 countries and areas at risk of transmission are close to 50 percent of the world’s Population.1
More than 3 billion people live in malarious areas and the disease causes between 1 million and 3 million deaths each year .2
Recent estimates of the global falciparum malaria morbidity burden have increased the number to 515 million cases .
Almost 5 billion clinical episodes of malaria occur in endemic areas annually, with more than 90 percent of this burden occurring in Africa .2,3
PAKISTAN SITUATION
PAKISTAN SITUATION Malaria is the second most prevalent and devastating disease in the
country (HMIS 2006). Transmission is seasonal and prone to epidemic outbreaks in certain geographical areas of Baluchistan NWFP and sindh. The disease is now emerging as prominent health problem in FATA.
Major malaria transmission season in Pakistan is post-monsoon (Sep-Nov) however along the costal areas and western border areas of country , the disease prevails throughout the year.5
Estimated number of annual malaria episodes in Pakistan is 1.5 million. The primary vector species are A. culicificies and
A. stephensi. P. falciparum and P. vivax are widely distributed in the country.
STRATIFICATION OF BURDEN BY CASES REPORTED
Malaria Occurrence (API) by district
More than 3.5
1.6 – 3.5
0.5 – 1.5
Less than 0.5
No data available
MAGNITUDENo. of reported cases (source: directorate of national malaria control program)
YEAR 1998 1999 2000 2001 2002 2003 2004 2005
REPORTED CASES
73516 91774
82526
104003
101761
125152
126719
127825
(% age increase
42.4)
In 2005, falciparum malaria constituted 33% of reported confirmed malaria cases. In the same period, 46% of cases were reported from Baluchistan province with highest proportion of falciparum malaria, i.e. 44%.
CAUSES OF TREATMENT FAILURE OF MALARIA CONTROL IN PAKISTAN
AT DIAGNOSIS STAGE
Quality of microscopy services
Maintainance of lab equipment
Lack of trained staff AT PATIENT LEVEL
Patient compliance and practice of self medication
DRUGS
overprescription
shortage at facility
unofficial drug sellers in private sector
The high costs of drugs may lead people to unofficial sources, which will sell a single tablet instead of a complete course of treatment, and subsequently to increased, often irrational demand for more drugs and more injections. Increasingly people are resorting to self-medication for malaria .
DRUG RESISTANCE
Drug resistance in Bannu district, a malaria-endemic area in Pakistan, molecular-based analyses were undertaken . all (100%) P. falciparum isolates exhibited the key chloroquine resistance mutation,, which is also associated with resistance to amodiaquine. These results indicate an emerging multi-drug resistance problem in P. vivax and P. falciparum malaria parasites in Pakistan.9
DATA AVAILABILITY
In 2006 Malaria Disease surveillance program registered 3.5 million slides prepared and 127,825 confirmed cases of malaria with Annual Parasite Incidence (API) of 0.8 cases per 1000 populations. 11. However according to another estimate the actual case load may be 5 times higher since public sector diagnosis facilities does not cover more than 20-30% of the attending patients and other 80% which get their treatment from private sector .
Continued…….
Continued ………
LACK OF COMMUNITY AWARENESS Lack of awareness about hygiene and sanitation practices.
Communities are unable to manage these health problems due to lack of knowledge about the causes of these diseases and access to appropriate health services. 12,19
INSECTICIDE RESISTANCE
Insecticide resistance (karachi study) pyrethroid ,malathion in the mosquitoes in pakistan
Continued……
KEY DETERMINANTS OF MALARIA
PROJECT (TEST PROJECT)
AIM ELIMINATION OF MALARIA FROM
PAKISTAN .OBJECTIVE To decrease the morbidity and mortality
associated with malaria in LORALAI district of Balochistan
To decrease treatment failure of malaria by 50% in LORALAI in 3 years
LORALAI
EXISTING STRATEGY.
SURVEILLANCE
MULTIPLE PREVENTION
EPIDEMIC PREPAREDNESS
BCCOPERATIONAL
RESEARCH
CASE MANAGEMENT
PARTNERSHIPBUILDING
MALARIACONTROL
STRATEGIES
PREVENTIVE
CURATIVE
BCCPersonal protectionVector controlEarly diagnosis /treatment
•RDT use promotion•Training of staff (microscopists)•Upgrading infrastructure(equipment)
•Public private partnership•Coordination of different departments(planning, environment,sanitation & meteriology)•Use of neo pesticides
•Drug policy change
•Registration of drugs by pharmacist
•sale on prescription
Malaria surveillance centersResearch centers.
PRIORITIES 1- Community based interventions: Arranging health education sessions weekly at the
centers/tents about available options for protection.Distribution of health education material to the
people (availability & use of LLIN ,ITN retreatment).Meeting with influential persons, imams and select
community volunteers from each area.Training of community based service provider like
LHW.School teachers and students to be invited to
attend the sessionsDisplay of charts and health education material at
sessions
BEHAVIORAL CHANGE COMMUNICATION
WE ARE DETERMINED TO ERADICATE MALARIA
Newspaper & local print media(danger signs)Wall painting with slogans Announcements in mosques by religious people.Weekly based program on FM radio stations/Tv plays (buzz & bite).
2- CURATIVEInitially after identification of the high risk clusters areas within the district
RDT will be given to the BHU. Staff will be trained for the use of RDT.Drug policy change regarding dispensing at private and public
sector(registration)Drug inspectors to check the quality and quantity from the registration
registers.Provision of revised guidelines for malaria control at every BHU(ban on
monotherapies)
Continued…….
3-Meetings for the Coordination between departments like Meteriology planning ,environment, agriculture for the sharing of information and thus helping in future preventive strategy for malaria.
4-Meetings for the Sharing of data between private and public sector regarding confirmed cases and drug use.
5-Replacement of organophosphates by neopesticide (neem)
6-Upgrading of Malaria control centre (surveillance +research)
Continued….
COST OF PROJECT
STRATEGY COMPONENTS
AMOUNT SPEND IN MILLIONS (rupees)
EARLY DIAGNOSIS AND TREATMENT 3 MILLION
MULTIPLE PREVENTION
5 MILLION
BCC
8 MILLION
INSTITUTIONAL STRENGTHENING
2 MILLION
CONTINGENCIES 1 MILLION
TOTAL 19MILLION
MONITORING PROCESS INDICATORS
No malaria cases per OPD Proportion of mothers trained on prevention of malaria in the
communities. Proportion of HF with copies of National Antimalarial treatment
Guidelines. Number of vector control teams established. Number of vector control teams strengthened. # of LLIN distributed to children under five. # of LLIN distributed to pregnant women # of Malaria microscopy slides taken # of Rapid diagnostic tests (RDTs) taken %age of Malaria cases that are laboratory confirmed # of Functional sentinel sites for monitoring antimalarial drug
resistance # of Functional sentinel sites for monitoring insecticide resistance.
EVALUATION IMPACT INDICATORSmalaria specific mortality ratemalaria infection prevalencemalaria case ratemalaria incidence EFFECT INDICATORSKAP SURVEY AFTER 3 YEAR
REFERENCES 1-Hay and others 2004; WHO 2005 2-(Breman 2001; Breman, Alilio, and Mills 2004; Carter and Mendis 2002; Snow and others 1999, 2003;
Snow, Trape, and Marsh 2001). 3-MALARIA SURVELLANCE REPORT 2003,pakistan 4-WWW.WHO.INT/COUNTRIE( WHO, Regional office for eastern meditteranean ,Rollback malaria) 5-dr.humayon rather guidelines of malaria control,ministry of health 6-http://202.83.164.26/wps/portal/Moh 7-WWW.WHO.INT/COUNTRIES/PK dated 30th oct2009 8-: Foster SD, Pricing, distribution, and use of antimalarial drugs”, Bull World Health Organ. 1991;69(3):349-
63. 9-- Khatoon L, Baliraine FN, Yan G,” Prevalence of antimalarial drug resistance mutations in Plasmodium
vivax and P. falciparum from a malaria-endemic area of Pakistan”. Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
-10- http://www.pakistan.gov.pk/divisions 11http://phkn.org.pk 12- M. J. Bouma, C. Dye AND H. J. van der Kaay , “Falciparum Malaria and Climate Change in the
Northwest Frontier Province of Pakistan” Medecins Sans Frontieres-Holland, Amsterdam, The Netherlands; London School of Hygiene and Tropical Medicine, London, United Kingdom; Laboratory for Parasitology, Medical Faculty, University of Leiden, Leiden, The Netherlands. Am. J. Trop. Med. Hyg., 55(2), 1996, pp. 131-137.
13 Shah I, Rowland MMehmood P, Mujahid C Razique F, Hewitt S,Durrani N “Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations”National Institute of Malaria Research and Training, Lahore, Pakistan. malaria@msfhni.psw.erum.com.pk
14-http://www.pakistan.gov.pk/divisions 15-WHO report 2008
THANKYOU
top related